HCRT and narcolepsy: Weinhold et al. [16] study demonstrated that intranasal administration of orexin-A in patients with narcolepsy with cataplexy significantly reduced daytime REM sleep duration (p = 0.041) and wake-REM sleep transitions (p = 0.022).